PDLIM7 and neoplasm: Regarding all four Chil1WT cell lines (Fig 6A–D), the data suggest that cells carrying the LMP1 transgene limit tumour growth in transgene-negative (WT) recipients, which may reflect immune rejection targeting LMP1, despite the very low levels of LMP1 typically observed in these cell lines (Hannigan & Wilson, 2010).